000			08107cam a2200721Ia 4500
001			on1244623089
003			OCoLC
005			20220526094103.0
006			m d
007			cr un|---aucuu
008			210403s2021 sz o 000 0 eng d
020			_a9783030679897 _q(electronic bk.)
020			_a3030679896 _q(electronic bk.)
020			_z9783030679880
020			_z3030679888
020			_a9783030679903 _q(print)
020			_a303067990X
020			_a9783030679910 _q(print)
020			_a3030679918
024	7		_a10.1007/978-3-030-67989-7 _2doi
035			_a2901702
035			_a(OCoLC)1244623089 _z(OCoLC)1244535524 _z(OCoLC)1253412844 _z(OCoLC)1284936867
040			_aEBLCP _beng _cEBLCP _dGW5XE _dYDX _dOCLCO _dEBLCP _dN$T _dUKAHL _dOCLCO _dVT2 _dLIP _dOCLCF _dQGK
049			_aMAIN
050		4	_aRC772.V5
072		7	_aMED044000 _2bisacsh
072		7	_aMJCM _2bicssc
072		7	_aMJCM _2thema
082	0	4	_a616.2/41406 _223
245	0	0	_aAlternative medicine interventions for COVID-19 _h[electronic resource] / _cMuhammad Zia-Ul-Haq, May Nasser Bin-Jumah, Sarah I. Alothman, Hanan A. Henidi, editors.
260			_aCham : _bSpringer, _c2021.
300			_a1 online resource (291 p.)
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
500			_aTherapeutic Logic of TCM as COVID-19 Inhibitor.
504			_aReferences -- Chapter 5: Foods as First Defense Against COVID-19 -- Introduction -- Role of Nutrition and Diet in Prevention and Management of COVID-19 -- Prioritizing Nutrition Interventions During COVID-19 -- Grains -- Vegetables and Fruits -- Nuts -- Legumes -- Meat -- Milk and Milk Products -- Herbs -- Role of Vitamins in COVID-19 -- Vitamin A -- Vitamin B -- Vitamin C -- Vitamin D -- Vitamin E -- Role of Minerals in COVID-19 -- Iron -- Selenium -- Zinc -- Magnesium -- Role of Omega-3 Polyunsaturated Fatty Acids -- Nutrients for Immune System and Resilience in COVID-19 -- Nutrition in Lowering Stress and Depression in COVID-19 -- Food Choices for Diabetic Patients During COVID-19 -- Food Choices for Cardiovascular Patients During COVID-19 -- Food Choices for Cancer Patients During COVID-19 -- Food Choices for Patients with Digestive Disorders During COVID-19 -- Food Choices for Pulmonary Disease Patients During COVID-19 -- Malnutrition May Exacerbate COVID-19 -- Nutrition and Post-COVID Recovery -- Future Perspectives -- Conclusion -- References -- Chapter 6: Drugs for the Treatment of COVID-19 -- Introduction -- Dexamethasone -- Chloroquine -- Remdesivir -- Angiotensin-Converting Enzyme Inhibitors -- Spike Protein Inhibitors -- Conclusions -- References -- Chapter 7: COVID-19 Pandemic and Vaccines -- Introduction -- COVID-19 Vaccines: A Need of Time -- Coronavirus Vaccine Development: Challenges of the Past -- Vaccine Development Strategies -- Nucleic Acid Vaccines -- Protein Subunit Vaccines -- Inactivated or Live-Attenuated Virus Vaccines -- Virus Vector-Based Vaccines -- Repurposed Vaccines for COVID-19 and Off-Target Effects of Other Vaccines -- Plant-Based Vaccines -- Animal Models for SARS-CoV-2 Studies -- Cell Culture Systems for SARS-CoV-2 Studies -- Clinical and Immunological Endpoints -- Vaccine Development Landscape.
505	0		_aIntro -- Preface -- Contents -- About the Editors -- Chapter 1: Introduction to COVID-19 -- Introduction -- Origin of COVID -- Emergence and Epidemiology -- Human-Animal Interaction as Risk Factor -- Best Suitable Animal Model -- COVID and Animal Welfare -- Molecular Differences Between Different Animal Species -- Vaccines for COVID from Animals -- Conclusion -- References -- Chapter 2: Medicinal Plants as COVID-19 Remedy -- Introduction -- Existing Plants with Potential Therapeutic Applications for Coronavirus Family (SARS-CoV) -- Plants as Specific Inhibitors of HCoV Target Proteins
505	8		_aBupleurum Species -- Artemisia annua L. -- Isatis indigotica Fortune ex Lindl. -- Alcea digitata (Boiss.) Alef. -- Lycoris radiata (L'H�er.) Herb. -- Pyrrosia lingua (Thunb.) Farw. -- Houttuynia cordata Thunb. -- Torreya nucifera L. -- Lindera aggregata (Sims) Kosterm. -- Rheum palmatum L. -- Cerasus avium (L.) Moench. -- Polygonum multiflorum Thunb. -- Citrus aurantium L. -- Rubia tinctorum L. -- Onopordum acanthium L. -- Quercus infectoria G. Olivier -- Crataegus microphylla C. Koch -- Berberis integerrima Bunge -- Alnus japonica (Thunb.) Steud. -- Paulownia tomentosa (Thunb.) Steud.
505	8		_aPsoralea corylifolia L. -- Tribulus terrestris L. -- Medicinal Plants as Potential Source of Natural Antiviral Agents Against COVID -19 -- Allium Sativum (Garlic) -- Azadirachta indica (Neem) -- Curcuma domestica (Turmeric, Haldi) -- Echinacea purpurea L. (Echinacea) -- Foeniculum vulgare Mill. (Fennel) -- Glycyrrhiza glabra (Licorice) -- Melissa officinalis L. (Lemon Balm) -- Mentha piperita L. (Peppermint) -- Nigella sativa L. (Black Seeds) -- Origanum vulgare L. (Oregano) -- Ocimum bacilicum L. (Basil) -- Rosmarinus officinalis L. (Rosemary) -- Salvia officinalis L. (Sage)
505	8		_aSenna alexandrina Mill. (Senna Makki) -- Zingiber officinale Rosc. (Ginger) -- Limitations -- Conclusions -- References -- Chapter 3: Traditional Chinese Medicines as Possible Remedy Against SARS-CoV-2 -- Introduction -- Traditional Chinese Medical Practices -- Laws for TCM Formulation -- Antiviral Potential of Plant Metabolites -- Structure of SARS-CoV-2 -- Relevance of SARS-CoV with SARS-CoV-2 -- Entry of SARS-CoV vs. SARS-CoV-2 into Host Cell -- TCM and SARS-CoV -- TCM and SARS-CoV-2 (COVID-19) -- Most Practiced Herbs in Formulations Against COVID-19
505	8		_aUtilization Frequency of Herbs in the Formulation of (COVID-19) Decoctions -- Approved/Proposed Decoctions with Successful Clinical Trials -- Qingfei Paidu Decoction (QFPD) (Approved) -- Huashi Baidu Decoction (HBD) (Approved) -- Xiaochaihu Decoction (XCHD) -- Xuanfei Baidu Decoction (XFBD) (Approved) -- Jinhua Qinggan (JQ) (Approved) -- Huoxiang Zhengqi (HZ) Capsule -- Lianhua Qingwen (LQ) -- Xuebijing Injection (XbI) (Approved) -- Reduning Injection (RdI) -- Shufeng Jiedu Capsule (SFJC) -- Ma Xing Shi Gan Decoction (MXSGD) (Approved) -- Yin Qiao San (YQS) -- Yupingfeng San (YPFS)
520			_aThis research volume examines the available alternative, complementary, pharmaceutical and vaccine methods for treating, mitigating, or preventing COVID-19. Coverage includes traditional Chinese medicine, herbal remedies, nutraceutical/dietary options, and drug/vaccine therapies. All the methods discussed will be critically examined to provide readers with a full, unbiased overview that includes pros/cons of each method. While the nature of COVID-19 is still being studied, and new research and theories are being published daily, this book endeavors to provide readers with a comprehensive summary of current research on alternative and mainstream treatment and prevention methods.
588	0		_aOnline resource; title from PDF title page (SpringerLink, viewed April 22, 2021).
590			_aWorldCat record variable field(s) change: 072
650		0	_aCOVID-19 (Disease) _xAlternative treatment.
650		7	_aAlternative medicine. _2fast _0(OCoLC)fst00806153
650		7	_aBehavior therapy. _2fast _0(OCoLC)fst00829929
650		7	_aFood _xBiotechnology. _2fast _0(OCoLC)fst00930473
650		7	_aImmunology. _2fast _0(OCoLC)fst00968006
650		7	_aNutrition. _2fast _0(OCoLC)fst01042187
650		7	_aVirology. _2fast _0(OCoLC)fst01167670
655		4	_aElectronic books.
700	1		_aZia-Ul-Haq, Muhammad, _cPh.D.
700	1		_aBin-Jumah, May Nasser.
700	1		_aAlothman, Sarah I.
700	1		_aHenidi, Hanan A.
776	0	8	_iPrint version: _aZia-Ul-Haq, Muhammad _tAlternative Medicine Interventions for COVID-19 _dCham : Springer International Publishing AG,c2021 _z9783030679880
850			_aSHTL
856	4	0	_3EBSCOhost _uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2901702
942			_2nlm _cEBK
999			_c36096 _d36096